Verition Fund Management
STIM icon

Verition Fund Management’s Neuronetics STIM Stock Holding History

Verition Fund Management’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-18,048
Closed -$24.9K – 3452
2025
Q4 		$24.9K Hold
18,048
– – ﹤0.01% 3417
2025
Q3 		$49.3K Hold
18,048
– – ﹤0.01% 3657
2025
Q2 		$63K Sell
18,048
-102,049
-85% -$403K ﹤0.01% 3516
2025
Q1 		$442K Buy
+120,097
New +$438K ﹤0.01% 2659
2020
Q3 		– Sell
-40,000
Closed -$77K – 1345
2020
Q2 		$77K Buy
+40,000
New +$82K ﹤0.01% 1011

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Verition Fund Management's STIM Position: Q1 2026 in Review

Verition Fund Management sold out of Neuronetics (STIM) in Q1 2026, closing a stake of 18,048 shares — an estimated $24.9K sold.

Verition Fund Management first reported a position in STIM in Q2 2020 and held it in 5 quarters. The position peaked at $442K in Q1 2025. 99 funds tracked by Wall St. Rank hold STIM as of Q1 2026.

  • Verition Fund Management reported no remaining Neuronetics position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 18,048 Neuronetics shares in Q1 2026, an estimated $24.9K.
  • Verition Fund Management first reported a position in Neuronetics in Q2 2020 and held it in 5 quarters.
  • Verition Fund Management's Neuronetics position peaked at $442K in Q1 2025.
  • 99 funds tracked by Wall St. Rank held Neuronetics as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.